KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Inventory Average (2016 - 2025)

Amgen has reported Inventory Average over the past 16 years, most recently at $6.3 billion for Q4 2025.

  • Quarterly results put Inventory Average at $6.3 billion for Q4 2025, down 12.46% from a year ago — trailing twelve months through Dec 2025 was $6.3 billion (down 12.46% YoY), and the annual figure for FY2025 was $6.6 billion, down 19.94%.
  • Inventory Average for Q4 2025 was $6.3 billion at Amgen, down from $6.5 billion in the prior quarter.
  • Over the last five years, Inventory Average for AMGN hit a ceiling of $9.1 billion in Q1 2024 and a floor of $4.0 billion in Q1 2021.
  • Median Inventory Average over the past 5 years was $5.0 billion (2023), compared with a mean of $5.8 billion.
  • Biggest five-year swings in Inventory Average: soared 83.5% in 2024 and later decreased 24.75% in 2025.
  • Amgen's Inventory Average stood at $4.1 billion in 2021, then increased by 17.59% to $4.8 billion in 2022, then surged by 50.14% to $7.3 billion in 2023, then decreased by 1.27% to $7.2 billion in 2024, then dropped by 12.46% to $6.3 billion in 2025.
  • The last three reported values for Inventory Average were $6.3 billion (Q4 2025), $6.5 billion (Q3 2025), and $6.7 billion (Q2 2025) per Business Quant data.